AGX101
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AGX101, covering 2026-02-11 to 2026-02-11. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors [Phase 1]